12/23/2003

Corixa and Medicis have decided to stop development of a treatment for the skin disorder. Corixa's PVAC treatment would have been used on mild-to-moderate conditions, but officials says they have decided to focus on "better products in (the) pipeline."

Full Story:
SeattlePI.com

Related Summaries